Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 13, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	297	67	117	45	148	56
Market Cap Growth	300.02%	-42.84%	161.30%	-69.80%	165.90%	72.90%
Enterprise Value	460	190	207	59	149	53
Last Close Price	8.15	1.85	3.24	1.24	5.48	2.98
PS Ratio	58.37	12.94	25.86	8.14	33.18	67.83
PB Ratio	-	-1.39	-3.65	1.24	5.85	2.96
P/TBV Ratio	-	-	-	1.38	6.78	3.63
EV/Sales Ratio	90.95	36.75	45.66	10.69	33.23	64.37
Debt / Equity Ratio	-1.86	-2.63	-3.75	1.35	1.50	0.70
Net Debt / Equity Ratio	-1.70	-2.44	-3.33	0.94	1.09	0.19
Net Debt / EBITDA Ratio	-5.11	-2.85	-2.68	-0.94	-1.22	-0.17
Net Debt / FCF Ratio	-5.94	-2.97	-1.92	-0.98	-1.11	-0.18
Asset Turnover	0.05	0.06	0.05	0.07	0.08	0.03
Quick Ratio	0.11	0.21	1.03	0.94	2.76	1.52
Current Ratio	0.12	0.23	1.16	1.09	3.12	1.62
Return on Equity (ROE)	-	-	-3439.35%	-120.10%	-104.65%	-132.62%
Return on Assets (ROA)	-22.20%	-28.70%	-26.32%	-27.89%	-27.25%	-41.53%
Return on Capital Employed (ROCE)	66.10%	-111.10%	-49.90%	-52.10%	-36.70%	-65.80%
Earnings Yield	-15.81%	-28.26%	-58.95%	-82.37%	-15.60%	-39.73%
FCF Yield	-9.24%	-58.90%	-47.45%	-77.40%	-16.76%	-34.20%
Buyback Yield / Dilution	-0.16%	-63.71%	-5.20%	-42.27%	-46.84%	-104.93%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q